Etiometry 2025 Highlights and Looking Ahead to 2026

Blog

Etiometry is proud to celebrate a year of meaningful achievements in 2025, driven by close collaboration and a shared commitment to improving patient care.
In 2025, Etiometry achieved significant momentum in advancing AI-driven clinical intelligence and supporting critical care teams:

2025 Highlights:

  • Delivered major platform advancements and expanded hospital adoption, informing the care of more than 425,000 patients to date.
  • Secured our 10th FDA clearance, validating enhanced cybersecurity protections for hospitals and patients.
  • Advanced the platform with deeper incorporation of high-resolution waveform data, enabling richer physiological insights at the point of care.
  • Earned the 2025 Digital Health Hub Award – Best in Class: AI in Patient Care at the HLTH conference.
  • Published a record number of clinical studies with leading institutions, strengthening evidence across pediatric and adult critical care.
  • Continued focus on our Cardiac Critical Care Solution, supporting clinicians by organizing and displaying patient data to aid decision-making in intensive care settings.
  • Added the highest number of hospitals in company history, with notable growth among major health systems.
  • Expanded internationally, strengthening our presence in Europe and the Middle East through strategic partnerships.

As Shane Cooke, President and CEO of Etiometry, noted, the platform plays a proven role in improving care quality, reducing length of stay and ICU readmissions, lowering costs, easing care team burden, and improving documentation of complications.


Looking Ahead to 2026:

We are building on this momentum with a clear focus on:

  • Expanding our presence in the adult cardiac market.
  • Accelerating international expansion in Europe and the Middle East.
  • Continuing to advance solutions to help identify and manage life-threatening conditions, including cardiogenic shock, respiratory failure, and sepsis/ARDS.


With appreciation,
The Etiometry Team

Related

First Automated Hospital-Specific Cardiogenic Shock Classification Tool for Critical Care Teams

Etiometry has received FDA clearance (K254066) for the Etiometry Cardiogenic Shock Tool: the first-ever automated solution for hospital-specific cardiogenic shock classification and tracking (aligned with each institution’s own protocols) using physiologic monitoring data. This is Etiometry’s 11th FDA clearance overall, and the only solution that automates SCAI staging directly from physiologic monitoring data. For cardiac […]

Etiometry Receives a First-Ever FDA Clearance for Automating Hospital-Specific Cardiogenic Shock Classification and Tracking

BOSTON, Mass. – April 8, 2026 – Etiometry, a leader in AI-driven clinical intelligence, today announced it has received FDA clearance (K254066) for the first-ever solution for automation of hospital-specific cardiogenic shock classification and tracking by directly utilizing data from physiologic monitoring, the Etiometry Cardiogenic Shock Tool.  Cardiogenic shock remains a critical challenge, with delayed identification […]

Boston Children’s enhances care with clinical intelligence platform

At Boston Children’s Hospital, Dr. Peter Laussen and Dr. Joshua Salvin are leading the way as true pioneers in clinical intelligence and AI. Through ongoing collaboration, their work has evolved to better integrate and interpret complex patient data, helping care teams shift toward more informed, data-driven decision-making in real time. Read how they helped shape […]